SC 13D 1 sc13d_biotex.htm SCHEDULE 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934*

(Amendment No.            )

BIOTEX HOLDINGS, INC.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

None

(CUSIP Number)

1400 Cypress Creek Road, Fort Lauderdale, Florida 33309

954-776-6600

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

COPY TO:

Anslow & Jaclin, LLP
195 Route 9 South, Suite 204
Manalapan, New Jersey   07726

(Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications)

 

June 9, 2005

(Dates of Events which Require Filing of this Statement)

 

 


 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [_] Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 


 

 

SCHEDULE 13D

 

(1)

Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons (entities only):

 

 

 

 

 

 

 

SCOTT J. SILVERMAN

 

 

 

 

 

 

(2)

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

 

 

 

 

 

(a)
(b)

 

 

 

 

 

 

(3)

SEC Use Only

 

 

 

 

 

 

(4)

Source of Funds (See Instructions):

SC

 

 

 

 

 

(5)

Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)

 

 

 

 

 

 

(6)

Citizenship or Place of Organization:

United States of America

 

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With

(7)

Sole Voting Power:

900,000

 

 

 

(8)

Shared Voting Power:

0

 

 

 

(9)

Sole Dispositive Power:

900,000

 

 

 

(10)

Shared Dispositive Power:

0

 

 

 

 

(11)

Aggregate Amount Beneficially Owned by Each Reporting Person:

900,000

 

 

 

 

 

(12)

Check if the Aggregate Amount in Row (11) Excludes Certain Shares

 

 

 

 

 

 

(13)

Percent of Class Represented by Amount in Row (11):

7.01%.

 

 

 

 

 

(14)

Type of Reporting Person:

IN

 

 

 

 

 

 

 


 

 

 

ITEM 1.   

SECURITY ISSUER.

BioTex Holdings, Inc.

1400 Cypress Creek Road, Fort Lauderdale, Florida 33309

ITEM 2.   

IDENTITY AND BACKGROUND.

(a)

Name:

Scott J. Silverman

 

 

 

(b)

Residence or business address:

1400 Cypress Creek Road, Fort Lauderdale, Florida 33309

 

 

 

(c)

Present principal occupation or employment and the name,
principal business and address of any corporation or other
organization in which such employment is conducted;

President-Bio-Tech Holdings, Inc.

 

 

 

(d)

Whether or not, during the last five years, such person has
been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) and, if so, give the dates,
nature of conviction, name and location of court, and penalty
imposed, or other disposition of the case;

None

 

 

 

(e)

Whether or not, during the past five years, such person
was a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction and as a result of such proceeding
was or is subject to judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation
with respect to such laws; and, if so, identify and describe such
proceedings and summarize the terms
of such judgment, decree or final order; and

None

 

 

 

(f)

Citizenship.

United States of America

 

 

 

 

 


 

 

ITEM 3.   

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

The Reporting Person, Scott J. Silverman, received 900,000 shares of Issuer pursuant to a Stock Purchase Agreement and Share Exchange between the Issuer and YB Holdings, Inc. whereby the Issuer acquired all of the issued and outstanding shares of YB Holdings, Inc. and it became the Issuer’s wholly owned subsidiary.

ITEM 4.   

PURPOSE OF TRANSACTION.

The acquisition by the Reporting Person was based on the transaction described in Item 3 above.

ITEM 5.   

INTEREST IN SECURITIES OF THE ISSUER.

Scott Silverman’s securities interest in the Issuer represented 7.01% of the total issued and outstanding common shares.

ITEM 6.     CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

Other than as described in this Schedule 13D, the Reporting Person has no contracts, arrangements, understandings or relationships with any other person with respect to any securities of the Issuer.

ITEM 7.   

MATERIAL TO BE FILED AS EXHIBITS.

Stock Purchase Agreement and Share Exchange between Issuer and YB Holdings, Inc. filed with the Form 8-K on June 15, 2005

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

June 30, 2005

Date

 

/s/  Scott J. Silverman Signature

 

Scott Silverman, President

Name and Title